Reproducible, ultra-sensitive, non-fluorescent signal generation and detection technology based on nanometer-sized metal colloidal particles
Genicon Sciences says it has amended its distribution, co-promotion, and supply agreement with Qiagen, whereby Genicon Sciences and Qiagen will have co-exclusive distribution rights in North America for nucleic acid microarray toolkit products incorporating Genicon Sciences's proprietary resonance light scattering (RLS) technology.
The arrangement will allow both companies to bring RLS technology to the market rapidly and efficiently.
Genicon Sciences, manufacturer and developer of the nucleic acid products, will commercialise them as part of the RLS array detection system, while the Qiagen products will be sold under the HiLight brand name.
Genicon Sciences's RLS technology is a reproducible, ultra-sensitive, non-fluorescent signal generation and detection technology based on nanometer-sized metal colloidal particles - RLS Particles - that can be used as ultra-sensitive biological labels in a wide variety of analytical bioassays critical in the drug discovery process and clinical diagnostics.
When illuminated with configured white light, RLS Particles generate intense, coloured, scattered light signals.
The sensitivity of RLS technology allows researchers to analyse nucleic acids, proteins, and biomarkers that are not normally detected by current standard assay microarray methods.
